Global Endovascular Aneurysm Repair Devices Market Size to grow at a CAGR of 5.85% to reach USD 4,613.26 million by 2032, Evaluates DelveInsight

According to DelveInsight's analysis, the increasing prevalence of abdominal and thoracic aortic aneurysms (AAA and TAA) is a major driver of the Endovascular Aneurysm Repair (EVAR) market. With a growing aging population, there is rising demand for minimally invasive treatments like EVAR, which offer benefits such as shorter hospital stays, fewer complications, and faster recovery compared to traditional surgery. Moreover, ongoing technological advancements in EVAR devices such as more flexible stent grafts and enhanced imaging for precise placement are broadening their applicability to a wider patient population, further supporting market growth.

DelveInsight's "Endovascular Aneurysm Repair Devices Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Endovascular Aneurysm Repair Devices companies actively working in the market.

To know more about why North America is leading the market growth in the Endovascular Aneurysm Repair Devices market, get a snapshot of the report Endovascular Aneurysm Repair Devices Market Trends
https://www.delveinsight.com/sample-request/endovascular-aneurysm-repair-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Endovascular Aneurysm Repair Devices Overview
Endovascular Aneurysm Repair (EVAR) Devices are specialized medical tools used to treat aneurysms-abnormal bulges in blood vessels, most commonly in the aorta-through a minimally invasive procedure. These devices, typically stent grafts, are delivered via a catheter through small incisions in the groin to reinforce the weakened vessel wall, prevent rupture, and restore normal blood flow. EVAR devices offer an alternative to open surgery, reducing recovery time, complications, and hospital stays.

DelveInsight Analysis: The endovascular aneurysm repair devices market size was valued at USD 2,937.61 million in 2024 and is expected to grow at a CAGR of 5.85% from 2025 to 2032, reaching approximately USD 4,613.26 million by 2032.

Endovascular Aneurysm Repair Devices Market Insights
Geographically, North America is projected to hold the largest share of the endovascular aneurysm repair devices market. This leadership is driven by the rising prevalence of abdominal and thoracic aneurysms, along with increasing cases of hypertension, smoking, and atherosclerosis. The growing adoption of minimally invasive procedures, supportive healthcare initiatives by governments and key industry players, and heightened public awareness across the region are all expected to further stimulate market growth during the forecast period.

To read more about the latest highlights related to Endovascular Aneurysm Repair Devices, get a snapshot of the key highlights entailed in the Endovascular Aneurysm Repair Devices Insights
https://www.delveinsight.com/report-store/endovascular-aneurysm-repair-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Endovascular Aneurysm Repair Devices Market Report
• In April 2025, Gore announced the expansion of its Gore Tag conformable thoracic stent graft with Active Control system, following FDA approval of four new large-diameter tapered sizes: 34x28mm, 37x31mm, 40x34mm, and 45x37mm.
• In March 2025, the U.S. Food & Drug Administration announced that Philips has removed and discontinued the distribution of the Tack Endovascular System due to reported challenges experienced by users.
• In January 2024, W. L. Gore & Associates (Gore) announced FDA approval for the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE), the first off-the-shelf endovascular solution for the treatment of complex aneurysmal disease involving the visceral aorta.
• In May 2023, Terumo Corporation announced that the US Food and Drug Administration (FDA) granted approval of the Relay®Pro Thoracic Stent-Graft device for the treatment of dissection and transection in the United States.
• Thus, owing to such developments in the market, rapid growth will be observed in the Endovascular Aneurysm Repair Devices market during the forecast period

Key Players in the Endovascular Aneurysm Repair Devices Market
Some of the key market players operating in the Endovascular Aneurysm Repair Devices market include- Medtronic PLC, Cook, W.L. Gore & Associates, Inc., Terumo Corporation, Endologix LLC., MicroPort Scientific Corporation, Lombard Medical, Viz.ai, Cardinal Health Inc., Cordis Corporation, Koninklijke Philips N.V., Becton, Dickinson and Company, Endoron Medical Ltd., Abbott, Getinge AB, and others.

Which MedTech key players in the Endovascular Aneurysm Repair Devices market are set to emerge as the trendsetter explore @ Key Endovascular Aneurysm Repair Devices Companies
https://www.delveinsight.com/sample-request/endovascular-aneurysm-repair-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Endovascular Aneurysm Repair Devices Market Landscape
The EVAR market is further propelled by technological advancements that have made the procedure safer and more accessible to a wider patient population. Innovations such as more flexible and durable stent-grafts, improved imaging techniques for accurate graft placement, and enhanced delivery systems are enabling EVAR use in patients with complex anatomies previously considered unsuitable. Additionally, better post-procedural outcomes-such as lower rates of endoleaks and graft migration-have increased confidence among surgeons and patients in choosing EVAR over traditional surgery. For example, in March 2023, Viz.ai received FDA 510(k) clearance for its algorithm to detect suspected abdominal aortic aneurysms (AAAs), marking the first FDA-cleared AI solution for identifying and classifying suspected AAAs.
As a result of these factors, the EVAR devices segment is expected to generate significant revenue, driving the overall growth of the global endovascular aneurysm repair devices market during the forecast period.

Scope of the Endovascular Aneurysm Repair Devices Market Report
• Coverage: Global
• Study Period: 2022-2032
• Endovascular Aneurysm Repair Devices Market Segmentation By Product: Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm (TAA), and Thoracoabdominal Aortic Aneurysm (TAAA)
• Endovascular Aneurysm Repair Devices Market Segmentation By Product: Aortic Stents, Thoracic Aortic Aneurysm Grafts, and Others
• Endovascular Aneurysm Repair Devices Market Segmentation By Site: Infrarenal and Pararenal
• Endovascular Aneurysm Repair Devices Market Segmentation By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, and Others
• Endovascular Aneurysm Repair Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Endovascular Aneurysm Repair Devices Companies: Medtronic PLC, Cook, W.L. Gore & Associates, Inc., Terumo Corporation, Endologix LLC., MicroPort Scientific Corporation, Lombard Medical, Viz.ai, Cardinal Health Inc., Cordis Corporation, Koninklijke Philips N.V., Becton, Dickinson and Company, Endoron Medical Ltd., Abbott, Getinge AB, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Endovascular Aneurysm Repair Devices market will grow by 2032? Click to get a snapshot of the Endovascular Aneurysm Repair Devices Market Analysis
https://www.delveinsight.com/sample-request/endovascular-aneurysm-repair-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.